Happening Now: GINGRICH: Biden's empty words belie his actions

Topic - FDA

Related Stories

President Joe Biden speaks about the coronavirus in the State Dinning Room of the White House, Thursday, Jan. 21, 2021, in Washington. (AP Photo/Alex Brandon)

Biden faces pressure to aim higher in COVID-19 vaccine goals

FILE - This Nov. 15, 1995 file photo shows then Food and Drug Administration (FDA) Administrator David Kessler testifying on Capitol Hill in Washington. President-elect Joe Biden has picked Kessler to lead vaccine science in his drive to put 100 million shots into the arms of Americans in his administration's first 100 days and stem the COVID-19 pandemic. (AP Photo/Denis Paquin)

Biden taps former FDA chief Kessler to lead vaccine science

FILE - In this Jan. 2, 2021, file photo, a person completes a swab of their mouth at a Curative walk-up kiosk testing site for COVID-19 at the Garfield Community Center in Seattle. The U.S. Food and Drug Administration is warning patients and health care providers that a coronavirus test developed by California company Curative may produce false results. (AP Photo/Ted S. Warren, File)

Congress, LA take divergent paths after COVID test warning

EXPLAINER: US regulator weighs in on vaccine dosing debate

Chicken Kitchen owner Julio Salazar, left, buys hand sanitizer from Chainbridge Distillery owner Bela Nahori in Oakland Park, Fla., on Tuesday, Aug. 11, 2020. The local distillery was given FDA approval to stop making spirits and instead make hand sanitizer at the start of the pandemic, but the demand has since plummeted and Nahori is currently overstocked. (John McCall /South Florida Sun-Sentinel via AP)

HHS overturns plan to slap $14,000 fee on distilleries who helped combat COVID

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

In this file photo, a man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continues to record ever-higher numbers of new cases, hospitalizations and deaths ahead of more holiday travel and family gatherings. FDA's OK is expected shortly after the all-day meeting concludes. (AP Photo/Bill Sikes, file) **FILE**

FDA panel takes up Moderna COVID-19 vaccine

FILE - A man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continues to record ever-higher numbers of new cases, hospitalizations and deaths ahead of more holiday travel and family gatherings. FDA's OK is expected shortly after the all-day meeting concludes. (AP Photo/Bill Sikes, file)

FDA plans to OK 2nd COVID-19 vaccine after panel endorsement

A droplet falls from a syringe after a health care worker was injected with the Pfizer-BioNTech COVID-19 vaccine at Women &amp; Infants Hospital in Providence, R.I., Tuesday, Dec. 15, 2020. (AP Photo/David Goldman)

Health officials track safety as COVID-19 vaccines roll out

Colleen Teevan, System Pharmacy Clinical Manager at Hartford HealthCare, administers the Pfizer-BioNTech vaccine for COVID-19 to healthcare worker Connor Paleski outside of Hartford Hospital, Monday, Dec. 14, 2020, in Hartford, Conn. (AP Photo/Jessica Hill)

U.S. vaccinations ramp up as 2nd COVID-19 shot nears

In this undated photo provided by Ellume the use of an at home self-administered rapid coronavirus test developed by Australian manufacturer Ellume is demonstrated. The test works with a smart phone app that can connect users to an online doctor consultation if they test positive. U.S. regulators on Tuesday, Dec. 15, 2020, allowed emergency use of the first rapid coronavirus test that consumers can buy without a prescription to test themselves entirely at home. The announcement by the Food and Drug Administration represents another important-- though incremental-- step in U.S. efforts to expand testing options for COVID-19 beyond health care facilities and testing sites. (Ellume via AP)

FDA authorizes first over-the-counter, fully at-home coronavirus diagnostic test

A truck is shown at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich., Saturday, Dec. 12, 2020. (AP Photo/Paul Sancya)

COVID-19 vaccine shipments begin in historic US effort

In this Aug. 23, 2020, file photo, President Donald Trump listens as Dr. Stephen Hahn, commissioner of the U.S. Food and Drug Administration, speaks during a media briefing in the James Brady Briefing Room of the White House in Washington. (AP Photo/Alex Brandon, File)

FDA says Pfizer vaccine approval is imminent; Trump wants it now: ‘Stop playing games’

White House threatens FDA chief’s job over vaccine approval

A vial of the Pfizer-BioNTech COVID-19 vaccine at the Royal Victoria Hospital, in Belfast, Tuesday, Dec. 8, 2020. The United Kingdom, one of the countries hardest hit by the coronavirus, is beginning its vaccination campaign, a key step toward eventually ending the pandemic. (Liam McBurney/Pool via AP)

FDA approves Pfizer vaccine for emergency use

Photos

More Photos

Quotations

Florida governor prepares for COVID-19 vaccine's first week →

White House threatens FDA chief's job over vaccine approval →

© Copyright 2021 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002

Switch to Desktop version